相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Substrate reduction therapy using Genz-667161 reduces levels of pathogenic components in a mouse model of neuronopathic forms of Gaucher disease
Shani Blumenreich et al.
JOURNAL OF NEUROCHEMISTRY (2021)
Elevated glucosylsphingosine in Gaucher disease induced pluripotent stem cell neurons deregulates lysosomal compartment through mammalian target of rapamycin complex 1
Manasa P. Srikanth et al.
STEM CELLS TRANSLATIONAL MEDICINE (2021)
Mice defective in interferon signaling help distinguish between primary and secondary pathological pathways in a mouse model of neuronal forms of Gaucher disease
Ayelet Vardi et al.
JOURNAL OF NEUROINFLAMMATION (2020)
GBA haploinsufficiency accelerates alpha-synuclein pathology with altered lipid metabolism in a prodromal model of Parkinson's disease
Masashi Ikuno et al.
HUMAN MOLECULAR GENETICS (2019)
Zebrafish acid ceramidase: Expression in Pichia pastoris GS115and biochemical characterization
Vijay B. Rajput et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Functionalized Cyclophellitols Are Selective Glucocerebrosidase Inhibitors and Induce a Bona Fide Neuropathic Gaucher Model in Zebrafish
Marta Artola et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
SignalP 5.0 improves signal peptide predictions using deep neural networks
Jose Juan Almagro Armenteros et al.
NATURE BIOTECHNOLOGY (2019)
Activity-Based Imaging of Acid Ceramidase in Living Cells
Yadira F. Ordonez et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
The EMBL-EBI search and sequence analysis tools APIs in 2019
Fabio Madeira et al.
NUCLEIC ACIDS RESEARCH (2019)
Role of β-glucosidase 2 in aberrant glycosphingolipid metabolism: model of glucocerebrosidase deficiency in zebrafish[S]
Lindsey T. Lelieveld et al.
JOURNAL OF LIPID RESEARCH (2019)
Glucocerebrosidase and its relevance to Parkinson disease
Jenny Do et al.
MOLECULAR NEURODEGENERATION (2019)
Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target
Yedda Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Molecular Mechanism of Inhibition of Acid Ceramidase by Carmofur
Alexey Dementiev et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Parallel Reaction Monitoring reveals structure-specific ceramide alterations in the zebrafish
Tejia Zhang et al.
SCIENTIFIC REPORTS (2019)
Reduced cerebral vascularization in experimental neuronopathic Gaucher disease
Nicholas J. C. Smith et al.
JOURNAL OF PATHOLOGY (2018)
Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease
Vagishwari Murugesan et al.
BLOOD CELLS MOLECULES AND DISEASES (2018)
Impact of sphingolipids on osteoblast and osteoclast activity in Gaucher disease
Matthew C. Reed et al.
MOLECULAR GENETICS AND METABOLISM (2018)
SWISS-MODEL: homology modelling of protein structures and complexes
Andrew Waterhouse et al.
NUCLEIC ACIDS RESEARCH (2018)
Acid ceramidase deficiency: Farber disease and SMA-PME
Fabian P. S. Yu et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Structural basis for the activation of acid ceramidase
Ahmad Gebai et al.
NATURE COMMUNICATIONS (2018)
Zebrafish as an Animal Model for Drug Discovery in Parkinson's Disease and Other Movement Disorders: A Systematic Review
Rita L. Vaz et al.
FRONTIERS IN NEUROLOGY (2018)
Interleukin 10 mutant zebrafish have an enhanced interferon gamma response and improved survival against a Mycobacterium marinum infection
Sanna-Kaisa E. Harjula et al.
SCIENTIFIC REPORTS (2018)
Lysosomal storage diseases
Frances M. Platt et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration
Federico N. Soria et al.
HUMAN MOLECULAR GENETICS (2017)
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
Jerome Stirnemann et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Glucosylsphingosine Causes Hematological and Visceral Changes in Mice-Evidence for a Pathophysiological Role in Gaucher Disease
Jan Lukas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease
Yumiko V. Taguchi et al.
JOURNAL OF NEUROSCIENCE (2017)
Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease
Manoj K. Pandey et al.
NATURE (2017)
Simultaneous quantitation of sphingoid bases by UPLC-ESI-MS/MS with identical 13C-encoded internal standards
M. Mirzaian et al.
CLINICA CHIMICA ACTA (2017)
Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases
Maria J. Ferraz et al.
FEBS LETTERS (2016)
Glucosylated cholesterol in mammalian cells and tissues: formation and degradation by multiple cellular β-glucosidases
Andre R. A. Marques et al.
JOURNAL OF LIPID RESEARCH (2016)
Lyso-glycosphingolipid abnormalities in different murine models of lysosomal storage disorders
Maria J. Ferraz et al.
MOLECULAR GENETICS AND METABOLISM (2016)
Identification of Modifier Genes in a Mouse Model of Gaucher Disease
Andres D. Klein et al.
CELL REPORTS (2016)
Elevation of glycoprotein nonmetastatic melanoma protein B in type 1 Gaucher disease patients and mouse models
Gertjan Kramer et al.
FEBS OPEN BIO (2016)
Development of an acid ceramidase activity-based probe
Cecile M. J. Ouairy et al.
CHEMICAL COMMUNICATIONS (2015)
Spinal muscular atrophy associated with progressive myoclonic epilepsy: A rare condition caused by mutations in ASAH1
Guido Rubboli et al.
EPILEPSIA (2015)
Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death
Marcus Keatinge et al.
HUMAN MOLECULAR GENETICS (2015)
Lentiviral Gene Therapy Using Cellular Promoters Cures Type 1 Gaucher Disease in Mice
Maria Dahl et al.
MOLECULAR THERAPY (2015)
Viable Neuronopathic Gaucher Disease Model in Medaka (Oryzias latipes) Displays Axonal Accumulation of Alpha-Synuclein
Norihito Uemura et al.
PLOS GENETICS (2015)
Neuroinflammatory paradigms in lysosomal storage diseases
Megan E. Bosch et al.
FRONTIERS IN NEUROSCIENCE (2015)
Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation
Shiny Nair et al.
BLOOD (2015)
Epithelial-Mesenchymal Transition in Kidney Tubular Epithelial Cells Induced by Globotriaosylsphingosine and Globotriaosylceramide
Yeo Jin Jeon et al.
PLOS ONE (2015)
Gaucher disease and Fabry disease: New markers and insights in pathophysiology for two distinct glycosphingolipidoses
Maria J. Ferraz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
Spatial and temporal expression patterns of chitinase genes in developing zebrafish embryos
Bjorn E. V. Koch et al.
GENE EXPRESSION PATTERNS (2014)
Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy
L. van Dussen et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2014)
Presence of two tumor necrosis factor (tnf)-α homologs on different chromosomes of zebrafish (Danio rerio) and medaka (Oryzias latipes)
Shunsuke Kinoshita et al.
MARINE GENOMICS (2014)
Plasma Lysosphingomyelin Demonstrates Great Potential as a Diagnostic Biomarker for Niemann-Pick Disease Type C in a Retrospective Study
Richard W. D. Welford et al.
PLOS ONE (2014)
Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity
Natalia Realini et al.
SCIENTIFIC REPORTS (2013)
Spinal Muscular Atrophy Associated with Progressive Myoclonic Epilepsy Is Caused by Mutations in ASAH1
Jie Zhou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Vascular Aspects of Fabry Disease in Relation to Clinical Manifestations and Elevations in Plasma Globotriaosylsphingosine
Saskia M. Rombach et al.
HYPERTENSION (2012)
Hypokinesia and Reduced Dopamine Levels in Zebrafish Lacking β- and γ1-Synucleins
Chiara Milanese et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria
Thomas P. Mechtler et al.
LANCET (2012)
Presenting your structures: the CCP4mg molecular-graphics software
S. McNicholas et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response
Nick Dekker et al.
BLOOD (2011)
The cytosolic β-glucosidase GBA3 does not influence type 1 Gaucher disease manifestation
Nick Dekker et al.
BLOOD CELLS MOLECULES AND DISEASES (2011)
Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy
Maria D. Sanchez-Nino et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Expression of the Paralogous Tyrosine Hydroxylase Encoding Genes th1 and th2 Reveals the Full Complement of Dopaminergic and Noradrenergic Neurons in Zebrafish Larval and Juvenile Brain
Alida Filippi et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2010)
Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage
Pramod K. Mistry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Laboratory and genetic evaluation of Gaucher disease
Olaf A. Bodamer et al.
WIENER MEDIZINISCHE WOCHENSCHRIFT (2010)
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
E. Sidransky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Murine models of acute neuronopathic Gaucher disease
Ida Berglin Enquist et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Validation of zebrafish (Danio rerio) reference genes for quantitative real-time RT-PCR normalization
Rongying Tang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2007)
Acid ceramidase and human disease
Jae-Ho Park et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
Genetic variation in the zebrafish
V Guryev et al.
GENOME RESEARCH (2006)
Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease
PB Deegan et al.
BLOOD CELLS MOLECULES AND DISEASES (2005)
Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention
RG Boot et al.
BLOOD (2004)
The reverse activity of human acid ceramidase
N Okino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Human acid ceramidase -: Processing, glycosylation, and lysosomal targeting
K Ferlinz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
